PeerVoice Heart & Lung Audio
20190
Average play count0
Played0
SubscribersRaffaele Califano, MD - At the Frontline in ALK+ NSCLC: Practical Approaches to TKI Therapy...
- 0
- 4 months ago
18:24
Isabel Conceição, MD - Prioritizing Patient-Centered Care for ATTR: Expert Perspectives on the Evolution of Data and Decision-Making...
- 0
- 4 months ago
53:06
Michael Thorpy, MD - When Sleep Is Exhausting: Improving Diagnosis and Outcomes in Patients With Idiopathic Hypersomnia...
- 0
- 5 months ago
01:28:44
Phyllis C. Zee, MD, PhD - Sleep, Heart, Brain: What Promotes and How to Reduce Cardiovascular Risk in Patients With Narcolepsy...
- 0
- 5 months ago
01:01:45
Jonathan W. Riess, MD, MS - The Central Role of the Pathologist in Detecting MET Alterations: Enabling Multidisciplinary Teams to Do More With Less in NSCLC...
- 0
- 6 months ago
32:53
Jonathan W. Goldman, MD - Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a Therapeutic Vulnerability in NSCLC...
- 0
- 8 months ago
57:55
Wisia Wedzicha, MD, FRCP - Taking the Evidence from Paper to Practice: Shared Perspectives on Practical Considerations in Comprehensive COPD Care...
- 0
- 9 months ago
23:45
George Kassianos, CBE, MD (Hons), FRCGP / Gili Regev-Yochay, MD - Current 2024 COVID-19 Vaccination Campaign: The Evidence Supporting the Call to Action...
- 0
- 9 months ago
11:16
David M. G. Halpin, MB BS, DPhil, FERS - The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of Disability and Death...
- 0
- 10 months ago
18:26
Perry Elliott, MD, FRCP - What’s New and What’s Next? Expanding Our Understanding of HCM in 2023...
- 0
- 11 months ago
24:37
Edward B. Garon, MD, MS - Abundance of Choice at First Line, Lack of Options Beyond: Addressing Unmet Needs in NSCLC Without Actionable Mutations...
- 0
- 11 months ago
20:40
Claus Vogelmeier, MD - Approaching Airway Inflammation From Another Angle: The Rationale for Targeting Type 2 Pathways in COPD...
- 0
- 11 months ago
20:54
Perry Elliott, MD, FRCP - Continuing Our Conversation in HCM: Compelling Questions and Evolving Considerations...
- 0
- 11 months ago
13:13
Laura Obici, MD - Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (ATTR): Shared Perspectives From Patients and Providers...
- 0
- 1 year ago
38:10
David Planchard, MD, PhD - Catching Up on CEACAM5 in NSCLC: The Whys and Hows of Detection and Targeting...
- 0
- 1 year ago
44:29
Wong Seng Weng, MBBS, MRCP, FAMS - Treatment Approaches in EGFR-Mutant NSCLC Post-TKI and Chemotherapy: What Now and What Next?...
- 0
- 1 year ago
54:35
Sarah Jarvis, MBE, FRCGP - Achieving Shared Goals Across the Spectrum of CKD and HF...
- 0
- 1 year ago
48:32
Mansoor Husain, MD - Integrating GLP-1 RAs Into Our Cardiology Care Pathways: Who, When, and Why?...
- 0
- 1 year ago
20:19
Kieran McCafferty, MB BChir, MRCP, MD (res) / Shelley Zieroth, MD, FRCPC, FHFSA (hon) - Handling Hyperkalaemia Without Compromising Care for Chronic Kidney Disease and Heart Failure...
- 0
- 1 year ago
36:25
Javier Cortés, MD, PhD - Updates on HER3-Targeted Therapies in NSCLC and Breast Cancer...
- 0
- 1 year ago
22:04
Michael Thorpy, MD - Dual Duty: Protecting Cardiovascular Health in Patients With Narcolepsy ...
- 0
- 1 year ago
54:44
D. Ross Camidge, MD, PhD - Mastering MET and cMET and Recognizing Their Role in Advanced NSCLC...
- 0
- 1 year ago
55:27
Sara A. Hurvitz, MD, FACP - Drug-Induced Interstitial Lung Disease and Breast Cancer: Knowing the Odds and Managing the Risk...
- 0
- 1 year ago
30:48
Sarah Jarvis, MBE, FRCGP - Identifying Intervention Points in CKD and HF From Multidisciplinary Viewpoints...
- 0
- 1 year ago
37:21
George L. Bakris, MD, MA - Step-by-Step: Setting a Course for Managing CKD and T2DM With Nonsteroidal MRAs...
- 0
- 1 year ago
24:44
Kevin Fernando, FRCGP, FRCP Edin., FAcadMEd - Simplified Strategies to Optimise Obesity Management for Primary Point of Contact Clinicians...
- 0
- 1 year ago
34:59
Angela Fitch, MD, FACP, Dipl. ABOM - Give the Heart a Break: Improving Cardiovascular Risk and Outcomes With Modern Weight Management Strategies...
- 0
- 1 year ago
33:47
Kausik Ray, MD, MPhil (Cantab), MBChB - Taking Obesity to Heart: The Role of the Cardiologist in Incorporating Obesity Care Into Cardiovascular Care to Enhance Patient Outcomes...
- 0
- 1 year ago
23:35
Franco Cecchi, MD - Improving Collaborative Care for HCM: Tips and Tricks From the Multidisciplinary Cardiology Team...
- 0
- 1 year ago
42:07
Payal Patel, MD, MPH - Rapid Diagnostic Testing: Getting the Upper Hand on Respiratory Tract Infections...
- 0
- 1 year ago
24:25
Perry Elliott, MD, FRCP, FESC - Thickening of the Heart, and HCM Is to Blame: A Call for Improved Recognition, Diagnosis, and Management of HCM...
- 0
- 1 year ago
18:23
Egbert F. Smit, MD, PhD - Novel Antigenic Targets for Antibody-Drug Conjugates in NSCLC...
- 0
- 2 years ago
20:11
Ewa A. Jankowska, MD, PhD - Breakthroughs and Game-Changers in Heart Failure...
- 0
- 2 years ago
27:18
Melanie J. Davies, CBE, FRCP, FMedSci - Proactive Stroke Risk Mitigation Strategies: Taking Aim in Type 2 Diabetes...
- 0
- 2 years ago
40:50
Wytske Fokkens, MD, PhD - Biologics for CRSwNP Management: Your Questions Answered...
- 0
- 2 years ago
21:28
Noemi Reguart, MD, PhD - Evaluating the Evidence for Emerging Therapies in NSCLC: Highlights From Summer/Fall 2022...
- 0
- 2 years ago
23:25
Javed Butler, MD, MPH, MBA - Changing the Patient Journey Across the Spectrum of Heart Failure...
- 0
- 2 years ago
22:04
Expert Guidance for Improving Outcomes in Advanced NSCLC: Utilising ADCs in Practice...
- 0
- 2 years ago
24:30
Right Drug, Right Patient, Right Time: Cases in “Precisionalised” Treatment of Advanced NSCLC...
- 0
- 2 years ago
27:59
Hot Topics and Controversies in Adjuvant Therapy for Early-Stage, EGFR-Mutant NSCLC...
- 0
- 2 years ago
24:14
New Biomarkers, New Targets in Advanced NSCLC...
- 0
- 2 years ago
20:20
Practical Guidance for Identifying and Managing Patients With Advanced MET Exon 14-Skipping NSCLC...
- 0
- 2 years ago
37:39
Insights on the Increasing Impact of Emerging Therapies in NSCLC: Highlights From Spring 2022...
- 0
- 2 years ago
19:16
Evolving Clinical Management of the Hospitalised COVID-19 Patient...
- 0
- 2 years ago
27:12
Managing Long-Chain Fatty Acid Disorders: Experience of Novel Therapies in the Real World...
- 0
- 2 years ago
24:06
Maintenance Therapy in COPD: Optimising Benefit With Inhalers When Ability to Inhale is Compromised...
- 0
- 2 years ago
26:36
Managing Thrombosis in Cancer: A Double Debacle and Then Add COVID...
- 0
- 2 years ago
21:28
Managing Complex Patients Hospitalized Due to COVID-19: Cases in Practice...
- 0
- 2 years ago
28:43
Biologics in Asthma and Nasal Polyposis: Decision-Making in Practice...
- 0
- 2 years ago
26:36
Description
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
Ages
Clean Content
No comments
